ATE320796T1 - Pharmazeutische zubereitung zur behandlung der analinkontinenz und analem juckreiz - Google Patents

Pharmazeutische zubereitung zur behandlung der analinkontinenz und analem juckreiz

Info

Publication number
ATE320796T1
ATE320796T1 AT97950311T AT97950311T ATE320796T1 AT E320796 T1 ATE320796 T1 AT E320796T1 AT 97950311 T AT97950311 T AT 97950311T AT 97950311 T AT97950311 T AT 97950311T AT E320796 T1 ATE320796 T1 AT E320796T1
Authority
AT
Austria
Prior art keywords
anal
treatment
pharmaceutical preparation
itching
incontinence
Prior art date
Application number
AT97950311T
Other languages
English (en)
Inventor
Michael Albert Kamm
Robin Kenneth Stewart Phillips
Original Assignee
Sla Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27268647&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE320796(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9626739.8A external-priority patent/GB9626739D0/en
Priority claimed from GBGB9626750.5A external-priority patent/GB9626750D0/en
Priority claimed from GBGB9703309.6A external-priority patent/GB9703309D0/en
Application filed by Sla Pharma Ag filed Critical Sla Pharma Ag
Application granted granted Critical
Publication of ATE320796T1 publication Critical patent/ATE320796T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
AT97950311T 1996-12-23 1997-12-23 Pharmazeutische zubereitung zur behandlung der analinkontinenz und analem juckreiz ATE320796T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9626739.8A GB9626739D0 (en) 1996-12-23 1996-12-23 Pharmaceutical composition for treating anal incontinence
GBGB9626750.5A GB9626750D0 (en) 1996-12-23 1996-12-23 Pharmaceutical composition for treating anal incontinence
GBGB9703309.6A GB9703309D0 (en) 1997-02-18 1997-02-18 Pharmacuetical composition for treating anal incontinence

Publications (1)

Publication Number Publication Date
ATE320796T1 true ATE320796T1 (de) 2006-04-15

Family

ID=27268647

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97950311T ATE320796T1 (de) 1996-12-23 1997-12-23 Pharmazeutische zubereitung zur behandlung der analinkontinenz und analem juckreiz

Country Status (11)

Country Link
US (3) US6635678B1 (de)
EP (1) EP0946155B2 (de)
JP (1) JP4246265B2 (de)
AT (1) ATE320796T1 (de)
AU (1) AU728889C (de)
CA (1) CA2275663C (de)
DE (1) DE69735552T3 (de)
DK (1) DK0946155T4 (de)
ES (1) ES2259806T5 (de)
PT (1) PT946155E (de)
WO (1) WO1998027971A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156780A (en) * 1996-10-17 2000-12-05 Milkhaus Laboratory, Inc. Treatment of fecal incontinence
JP4246265B2 (ja) * 1996-12-23 2009-04-02 エス・エル・アー・ファーマ・アクチエンゲゼルシャフト 大便失禁を治療するための医薬組成物
CZ20012113A3 (cs) * 1998-12-14 2001-11-14 Cellegy Pharmaceuticals, Inc. Prostředky a způsoby pro léčbu onemocnění anorektální oblasti
US6627632B2 (en) 1998-12-14 2003-09-30 Cellegy Pharmaceuticals, Inc. Compositions and methods for the treatment of anorectal disorders
GB0030580D0 (en) * 2000-12-15 2001-01-31 Medicare Man Consultancy Ltd Composition and method
GB0130763D0 (en) * 2001-12-21 2002-02-06 Norgine Res Ltd Treatment methods
JPWO2003070252A1 (ja) * 2002-02-22 2005-06-09 大正製薬株式会社 止痒剤
US20040266880A1 (en) * 2002-02-22 2004-12-30 Fumie Sato Antipruritics
US7737182B2 (en) * 2002-08-09 2010-06-15 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals for xerosis
JP3678366B2 (ja) * 2002-08-09 2005-08-03 大正製薬株式会社 止痒剤
AU2003301900A1 (en) * 2002-11-13 2004-06-03 Fumie Sato Antipruritic drug
WO2006041875A1 (en) * 2004-10-06 2006-04-20 Allergan, Inc. Novel prostamides for the treatment of glaucoma and related diseases
AU2012202731B2 (en) * 2005-06-17 2014-06-19 Wisconsin Alumni Research Foundation Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
AU2014202738B2 (en) * 2005-06-17 2016-05-12 Wisconsin Alumni Research Foundation Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
WO2006138691A1 (en) 2005-06-17 2006-12-28 Wisconsin Alumni Research Foundation Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
AU2016202290B2 (en) * 2005-06-17 2017-10-05 Wisconsin Alumni Research Foundation Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
US7553273B2 (en) 2006-05-01 2009-06-30 Duodyn Technology, Llc Apparatus and method for managing incontinence
US7828715B2 (en) 2006-06-29 2010-11-09 Ams Research Corporation Method of treating anal incontinence
BRPI0806234A2 (pt) * 2007-01-03 2011-09-06 Ams Res Corp unidade de implante pélvico, e, combinação de uma unidade de implante e um instrumento de inserção
PE20091084A1 (es) * 2007-12-07 2009-07-23 Schering Plough Healthcare Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
US20090156891A1 (en) * 2007-12-12 2009-06-18 Ams Research Corporation Prolapse and Perineal Repair Concepts
WO2010051933A2 (en) 2008-11-10 2010-05-14 Bayer Schering Pharma Aktiengesellschaft Substituted sulphonamido phenoxybenzamides
EP2491015A1 (de) 2009-10-21 2012-08-29 Bayer Pharma Aktiengesellschaft Substituierte benzosulfonamide
CA2777430A1 (en) 2009-10-21 2011-04-28 Bayer Pharma Aktiengesellschaft Substituted benzosulphonamides
WO2011047796A1 (en) 2009-10-21 2011-04-28 Bayer Schering Pharma Aktiengesellschaft Substituted halophenoxybenzamide derivatives
JP2013542214A (ja) 2010-10-29 2013-11-21 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 置換フェノキシピリジン類
CA2833420C (en) * 2011-04-26 2019-09-03 Rdd Pharma Ltd. Oxymetazoline for the treatment of ano-rectal disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593261A (en) 1976-07-23 1981-07-15 Inveresk Res Int Controlled release suppository
DK339289D0 (da) 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
NL9102142A (nl) 1991-12-20 1993-07-16 Dagra Pharma Bv Zetpillen met vertraagde afgifte en werkwijze voor de bereiding daarvan.
FR2697162B1 (fr) † 1992-10-23 1995-01-13 Lafon Labor Utilisation du modafinil pour la fabrication d'un médicament pour le traitement de l'incontinence urinaire et des troubles sphinctériens urétro vésicaux.
US5750141A (en) * 1993-04-08 1998-05-12 The University Of Queensland Administration of vaso-active agent and therapeutic agent
GB9422571D0 (en) 1994-11-09 1995-01-04 Whitehall Lab Ltd Haemorrihoidal compositions and method of use
US5595753A (en) * 1995-04-14 1997-01-21 President And Fellows Of Harvard College Topical formulations and methods for treating hemorrhoidal pain and sphincter and smooth muscle spasm in the gastrointestinal tract
JP4246265B2 (ja) * 1996-12-23 2009-04-02 エス・エル・アー・ファーマ・アクチエンゲゼルシャフト 大便失禁を治療するための医薬組成物

Also Published As

Publication number Publication date
US20030216420A1 (en) 2003-11-20
US6635678B1 (en) 2003-10-21
DK0946155T3 (da) 2006-07-31
DE69735552T2 (de) 2007-02-01
DE69735552T3 (de) 2009-08-13
JP4246265B2 (ja) 2009-04-02
WO1998027971A1 (en) 1998-07-02
AU5331598A (en) 1998-07-17
CA2275663C (en) 2008-03-18
EP0946155A1 (de) 1999-10-06
ES2259806T3 (es) 2006-10-16
DK0946155T4 (da) 2009-05-11
US20080058363A1 (en) 2008-03-06
CA2275663A1 (en) 1998-07-02
EP0946155B2 (de) 2009-01-21
ES2259806T5 (es) 2009-05-01
AU728889B2 (en) 2001-01-18
US7781444B2 (en) 2010-08-24
PT946155E (pt) 2006-07-31
US7928146B2 (en) 2011-04-19
EP0946155B1 (de) 2006-03-22
AU728889C (en) 2001-08-02
DE69735552D1 (de) 2006-05-11
JP2001507020A (ja) 2001-05-29

Similar Documents

Publication Publication Date Title
ATE320796T1 (de) Pharmazeutische zubereitung zur behandlung der analinkontinenz und analem juckreiz
AR052921A1 (es) Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica
NZ520083A (en) The modification of a patient's blood with ultra-violet light for the treatment of congestive heart failure
SE9703226D0 (sv) New pharmaceutical composition
KR980000447A (ko) 미르타자핀과 하나 이상의 선택적인 세로토닌 재이용 저해제로 이루어진 약학 조성물
ES2295609T3 (es) Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor.
EP2329842A3 (de) Interleukin-1 Inhibitoren zur Behandlung von Erkrankungen
CY1109827T1 (el) Χρηση της αλλαντοτοξινης για την αγωγη δυσκολα αντιμετωπισιμης δυσλειτουργιας κενωσης
EP1889614A3 (de) Verfahren zur Verwendung selektiver Serotonin-Wiederaufnahmehemmer mit schnellem Wirkungseintritt zur Behandlung sexueller Dysfunktionen
BR9910899A (pt) Compostos de ácido sulfÈnico ou sulfonilamino n-(hetero-aralquil)-azaeterocicliamida
KR950016760A (ko) 치질 치료제
WO2001022919A3 (en) Spiro[bicyclic -azacycloalkyl and -cycloalkyl] derivatives and uses thereof
ES2192840T3 (es) Laxante osmotico no fermentado para tratar y prevenir cancer colorrectal.
DK1000046T3 (da) Piperazinderivater, der er aktive på den nedre urinvejskanal
HRP20041150B1 (en) Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women
NO20005223L (no) Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen
NO20032411L (no) Anvendelse av substituerte 6-dimetylaminometyl-1-fenyl- cykloheksan-forbindelser for behandling av urininkontinens
RU2001118219A (ru) Ингибитор ангиогенеза
EA199800676A1 (ru) Способы повышения компетенции сфинктера
EA200001058A1 (ru) Новые способы лечения нервных расстройств
ATE271867T1 (de) Behandlung der harninkontinenz und zusammenstellung dafür
ATE341323T1 (de) Verwendung von darifenacin zur behandlung des harndrangs
BR0303384A (pt) Citalopram e seus usos no tratamento de pressão sanguìnea elevada
PT1347753E (pt) Composicao topica e metodo para o tratamento da incontinencia urinaria de stress
RU2000110676A (ru) Способ консервативного лечения стриктур уретры

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0946155

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 0946155

Country of ref document: EP